Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing.

Icon for Silverchair Information Systems Related Articles

Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing.

JAMA. 2018 Jun 19;319(23):2377-2378

Authors: Gill J, Obley AJ, Prasad V

PMID: 29800087 [PubMed – indexed for MEDLINE]